Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
皮下注射卡西利维单抗和伊姆维维单抗抗体组合与安慰剂对早期无症状SARS-CoV-2感染者发展为有症状COVID-19的影响：一项随机临床试验
期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2021.24939
O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Musser, Bret J; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Brown, Elizabeth R; Heirman, Ingeborg; Davis, John D; Turner, Kenneth C; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T; Hamilton, Jennifer D; Kim, Yunji; Purcell, Lisa A; Baum, Alina; Kyratsous, Christos A; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A Thomas; Geba, Gregory P; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D; Weinreich, David M
